Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 11/20 | 0.72 |
| ▸ | PPARA | Q07869 | 7/20 | 0.72 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.56 |
| ▸ | PPARD | Q03181 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 4/20 | 0.52 |
| ▸ | TP53 | P04637 | 2/20 | 0.52 |
| ▸ | POLB | P06746 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4106599 | 0.90 | PPARG (0.66) | PPARGPPARAFFAR1PPARDMAPT | |
| SCHEMBL4099878 | 0.90 | PPARG (0.66) | PPARGPPARAFFAR1PPARDMAPT | |
| SCHEMBL4099663 | 0.90 | PPARG (0.66) | PPARGPPARAFFAR1PPARDMAPT | |
| SCHEMBL4093286 | 0.90 | PPARG (0.66) | PPARGPPARAFFAR1PPARDMAPT | |
| SCHEMBL4103408 | 0.90 | PPARG (0.65) | PPARGPPARAFFAR1PPARDMAPT | |
| SCHEMBL4092782 | 0.86 | PPARG (0.64) | PPARGPPARAFFAR1PPARDMAPT | |
| SCHEMBL4098324 | 0.85 | FFAR1 (0.57) | PPARGPPARAFFAR1PPARDMAPT | |
| SCHEMBL4099124 | 0.84 | PPARG (0.63) | PPARGPPARAFFAR1MAPTTP53 | |
| SCHEMBL4103107 | 0.83 | FFAR1 (0.62) | PPARGPPARAFFAR1PPARDMAPT | |
| SCHEMBL4097707 | 0.83 | PPARG (0.60) | PPARGPPARAFFAR1MAPTTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090054435-A1 | Phenoxyalkanoic Acid Compound | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2009-02-26 | — | — | US | claimed |
| EP-1911738-A1 | PHENOXYALKANOIC ACID COMPOUND | Takeda Pharmaceutical Company Limited (JP) | 2008-04-16 | — | — | EP | claimed |
| US-20090054435-A1 | Phenoxyalkanoic Acid Compound | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2009-02-26 | — | — | US | disclosed |
| EP-1911738-A1 | PHENOXYALKANOIC ACID COMPOUND | Takeda Pharmaceutical Company Limited (JP) | 2008-04-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090054435-A1 | Phenoxyalkanoic Acid Compound | PNLIP, GPR119, LIPC | PPARG 23/4885PPARA 8/4885FFAR1 20/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.